Announcements Trials
Browse Landscape

Phase

Phase 1 28Phase 2 10Phase 1/2 8Phase EARLY_PHASE1 2Phase NA 1

Status

Recruiting 12Unknown 10Not yet recruiting 3Completed 3Terminated 2Withdrawn 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Breast Neoplasms 15Glioblastoma 14Neoplasms 12Melanoma 11Brain Neoplasms 11Head and Neck Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Pancreatic Neoplasms 9Lung Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Prostatic Neoplasms 8Glioma 8Ovarian Neoplasms 7Neoplasm Metastasis 7Lymphoma 6Colonic Neoplasms 6Multiple Myeloma 5Carcinoma, Hepatocellular 5Urinary Bladder Neoplasms 4Sarcoma 4Rectal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, T-Cell 4Lymphoma, Large B-Cell, Diffuse 4Hodgkin Disease 4Stomach Neoplasms 3Recurrence 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Leukemia, Myeloid, Acute 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Terminated × Solid Tumor × Clear all
NCT06094426 2026-04-29

Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors

Grit Biotechnology

Phase EARLY_PHASE1 Terminated
2 enrolled
Other solid neoplasm

Solid Tumor

NCT07108140 2026-01-22

Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors

TCRCure Biopharma Ltd.

Phase EARLY_PHASE1 Terminated
5 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡